Stereotactic Body Radiation Therapy With or Without Nivolumab in Treating Patients With Stage I-IIA or Recurrent Non-small Cell Lung Cancer
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Shanghai Pulmonary Hospital, Shanghai, China
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
Pfizer
Emory University
Sun Yat-sen University
Imugene Limited
M.D. Anderson Cancer Center
Fondazione del Piemonte per l'Oncologia
Jiangmen Central Hospital
Stanford University
Palo Alto Veterans Institute for Research
AstraZeneca
Jonsson Comprehensive Cancer Center
Intima Bioscience, Inc.
Karl Landsteiner University of Health Sciences
Ohio State University Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
Tizona Therapeutics, Inc
Guangdong Association of Clinical Trials
Amgen
Institut Bergonié
Tribhuvan University, Nepal
Alliance for Clinical Trials in Oncology
Second Life Therapeutics
SWOG Cancer Research Network
Lantern Pharma Inc.
Tango Therapeutics, Inc.
Alaunos Therapeutics
Jonsson Comprehensive Cancer Center
University of Pennsylvania
NRG Oncology
Turning Point Therapeutics, Inc.
Pfizer
BerGenBio ASA
Stony Brook University
Shanghai Pulmonary Hospital, Shanghai, China
Masonic Cancer Center, University of Minnesota
Mayo Clinic
National Cancer Institute (NCI)
Numab Therapeutics AG
Alliance for Clinical Trials in Oncology
Hacettepe University
SWOG Cancer Research Network
University of Pennsylvania
Novartis
SOLTI Breast Cancer Research Group